The following data is part of a premarket notification filed by Becton Dickinson & Co. with the FDA for Bbl Chromagar Mrsa Ii.
Device ID | K092767 |
510k Number | K092767 |
Device Name: | BBL CHROMAGAR MRSA II |
Classification | Culture Media, Antimicrobial Susceptibility Test, Excluding Mueller Hinton Agar |
Applicant | BECTON DICKINSON & CO. 7 LOVETON CIR. Sparks, MD 21152 |
Contact | Paul Swift |
Correspondent | Paul Swift BECTON DICKINSON & CO. 7 LOVETON CIR. Sparks, MD 21152 |
Product Code | JSO |
CFR Regulation Number | 866.1700 [🔎] |
Decision | Substantially Equivalent (SESE) |
Type | Traditional |
3rd Party Reviewed | No |
Combination Product | No |
Date Received | 2009-09-09 |
Decision Date | 2010-08-20 |
Summary: | summary |
Device Identifier | submissionNumber | Supplement |
---|---|---|
30382902153598 | K092767 | 000 |
30382902152287 | K092767 | 000 |
30382902152294 | K092767 | 000 |
30382902154212 | K092767 | 000 |